CMIC Group – アジア市場に関するホワイトペーパー

Expanding to Asia can be a logical next step for pharma companies looking to grow beyond the mature markets of North America and Europe. Recent developments in market access and regulatory rules in Japan and South Korea have paved the way for such expansion, by introducing a newly consultative approach to clinical trials, lowering